Hims & Hers Health, Inc. (HIMS) closed at $28.89 in the latest trading session, marking a -5.19% move from the prior day. The stock fell short of the S&P 500, which registered a gain of 1.16% for the ...

Hims & Hers and Tempus AI are transforming digital health in distinct ways, but which platform looks more compelling right ...

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 2.2% in the morning session after Morgan Stanley reiterated ...

Hims & Hers Health is significantly undervalued, with the market underestimating its growth potential and international expansion opportunities. Learn more about HIMS stock here.

The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, built its growth strategy around a highly scalable, ...

Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term losses lately. The San Francisco, CA-based ...

Hims & Hers Health, Inc. faces short-term pressure after missing Novo’s partner list, but lab testing boosts long-term growth ...

Hims & Hers is disrupting the healthcare industry, testing the limits of regulation to make it easier for people to buy popular drugs at lower prices online. This week, the telehealth company faced ...

Add Yahoo as a preferred source to see more of our stories on Google. The New York Stock Exchange with a Hims & Hers Health, Inc banner is pictured as a person runs past in the Manhattan borough of ...